Antibody binding to individual short consensus repeats of decay- accelerating factor enhances enterovirus cell attachment and infectivity

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2318-2323

  Shafren, Darren R ^a   Dorahy, Douglas J ^a   Thorne, Rick F ^a   Kinoshita, Taroh ^b   Barry, Richard D ^a   Burns, Gordon F ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ECHO VIRUS; ENTEROVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; ANTIGENS, CD55; BINDING SITES, ANTIBODY; CELL ADHESION; CELL MEMBRANE; CHO CELLS; CONSENSUS SEQUENCE; CRICETINAE; ENTEROVIRUS; ENTEROVIRUS B, HUMAN; HUMANS; RECEPTORS, FC; REPETITIVE SEQUENCES, NUCLEIC ACID; RHABDOMYOSARCOMA; SOLUBILITY; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS;

EID: 0032032886     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35.
2. Nicholson-Weller, A., and C. E. Wang. 1994. Structure and function of decay accelerating factor CD55. J. Lab. Clin. Med. 123:485.
3. Nicholson-Weller, A., J. P. March, C. E. Rosen, D. B. Spicer, and K. F. Austen. 1985. Surface membrane expression by human blood leucocytes and platelets of decay accelerating factor, a regulatory protein of the complement system. Blood 65:1237.
4. Zimmerman, A., H. Gerber , V. Nussenzweig, and H. Isliker. 1990. Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction. Virchows Arch. A Pathol. Pathol. Anat. 417:299.
5. Quigg, R. J., A. Nicholson-Weller, A. V. Cybulsky, J. Badalamenti, and D. J. Salant. 1989. Decay accelerating factor regulates complement activation on glomerular epithelial cells. J. Immunol. 142:877.
6. Koretz, K., S. Bruderlein, C. Henne, and P. Moller. 1992. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br. J. Cancer. 66:810.
7. Coyne, K. E., S. E. Hall, E. S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149:2906.
8. Moran, P., H. Beasley, A. Gorrell, E. Martin, P. Gibling, H. Fuchs, N. Gillett, L. E. Burton, and I. W. Caras. 1992. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J. Immunol. 149:1736.
9. Medof, M. E., T. Kinoshita, and V. Nussenzweig. 1984. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160:1558.
10. Hamann, J., B. Vogel, G. M. W. Van Schijndel, and R. A. W. van Lier. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1185.
11. Shafren, D. R., D. J. Dorahy, R. A. Ingham, G. F. Burns, and R. D. Barry. 1997. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule-1 for cell entry. J. Virol. 71:4736.
12. Nowicki, B., A. Hart, K. E. Coyne, D. M. Lublin, and S. Nowicki. 1993. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesion in a model of a cell-cell interaction. J. Exp. Med. 178:2115.
13. Shafren, D. R., R. C. Bates, M. V. Agrez, R. L. Herd, G. F. Burns, and R. D. Barry 1995. Coxsackieviruses B1, B3 and B5 use decay-accelerating factor as a receptor for cell attachment. J. Virol. 69:3873.
14. Bergelson, J. M., J. G. Mohanty, R. L. Crowell, N. F. St. John, D. M. Lublin, and R. W. Finberg. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69:1903.
15. Bergelson, J. M., B. M. Chan, K. R. Solomon, J. N. St. John, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245.
16. Clarkson, N. A., R. Kaufman, D. M. Lublin, T. Ward, P. A. Pipkin, P. D. Minor, D. J. Evans, and J. W. Almond. 1995. Characterisation of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol. 69:5497.
17. Medof, M. E., E. Waller, J. Rutgers, D. Knowles, and V. Nussenzweig. 1985. Soluble DAF in body fluids. Complement 2:53.
18. Kinoshita, T., M. E. Medof, R. Silber, and V. Nussenzweig. 1985. Distribution of decay accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 162:75.
19. Fujita, T., T. Inoue, K. Ogawa, K. Iida, and N. Tamura. 1987. The mechanism of action of decay-accelerating factor (DAF): DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J. Exp. Med. 167:1221.
20. Burns, G. F., T. Triglia, J. A. Werkmeister, C. G. Begley, and A. W. Boyd. 1985. TLiSA, A human lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J. Exp. Med. 161:1063.
21. Sugita, Y., T. Negoro, T. Matsuda, T. Sakamoto, and M. Tomita. 1986. Improved method for the isolation and preliminary characterisation of human DAF (decay-accelerating factor). J. Biochem. 100:143.
22. Ward, T., P. A. Pipkin, N. A. Clarkson, D. M. Stone, P. D. Minor, and J. W. Almond. 1994. Decay accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13:5070.
23. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection of HIV via Fc receptor-mediated entry. Science 242:580.
24. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:3183.
25. Mason, P. W., B. Baxt, F. Brown, J. Harber, A. Murdin, and E. Wimmer. 1993. Antibody-complexed Foot and Mouth Disease Virus, but not Poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568.
26. Faull, R. J., J. Wang, D. I. Leavesely, W. Puzon, G. R. Russ, D. Vestweber, and Y. Takada. 1996. A novel activating anti-β1 integrin monoclonal antibody binds to the cysteine-rich repeats in the β1 chain. J. Biol. Chem. 271:25099.